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ABSTRACT
Objective: Bilateral vestibulopathy (BV) leads to a
bilateral deficit of the vestibulo-ocular reflex and has
various aetiologies. The main goal of this study was to
determine the frequency and degree of recovery or
worsening of vestibular function over time.
Methods: 82 patients (59 males, 23 females; mean age
at the time of diagnosis 56.3 (SD 17.6) years) were re-
examined 51 (36) months after the first examination. All
patients underwent a standardised neuro-ophthalmologi-
cal and neuro-otological examination. Electronystag-
mography with bithermal caloric irrigation was analysed
by measurement of the mean peak slow phase velocity
(SPV) of the induced nystagmus. Patients evaluated the
course of their disease in terms of balance, gait
unsteadiness and health related quality of life.
Results: Statistical analysis of the mean peak SPV of
caloric induced nystagmus revealed a non-significant
worsening over time (initial mean peak SPV 3.0 (3.5)u/s
vs 2.1 (2.8)u/s). With respect to subgroups of aetiology,
only patients with BV due to meningitis exhibited an
increasing, but non-significant SPV (1.0 (1.4)u/s vs 1.9
(1.6)u/s). Vestibular outcome was independent of age,
gender, time course of manifestation and severity of BV.
Single analysis of all patients showed that a substantial
improvement >5u/s occurred in two patients on both
sides (idiopathic n = 1, Sjo¨gren’s syndrome n = 1) and in
eight patients on one side (idiopathic n = 6, meningitis
n = 1, Menie`re’s disease n = 1). In 84% of patients there
was impairment of their health related quality of life (42%
slight, 24% moderate, 18% severe). Forty-three per cent
of patients rated the course of their disease as stable,
28% as worsened and 29% as improved.
Conclusions: Our data support the view that more than
80% of patients with BV do not improve. Thus the
prognosis of BV is less favourable than assumed.
Bilateral vestibulopathy (BV) is characterised by
impaired or lost function of both peripheral
labyrinths or of the eighth nerves. The most
frequent complaint of patients with BV is unstea-
diness of gait with worsening in darkness and on
uneven ground due to deficient vestibulospinal
function. Some patients complain of oscillopsia (ie,
apparent motion of the visual scene during head
movements or when walking). Oscillopsia is
caused by involuntary retinal slip as a result of
an insufficient vestibulo-ocular reflex (VOR).
Furthermore, BV can also lead to impaired spatial
memory and navigation associated with hippo-
campal atrophy.1 The diagnosis of BV is based on
the head thrust test,2 3 a simple bedside test for
high frequency VOR function, and bithermal
caloric testing with oculographic recordings to test
for a low frequency VOR deficit. BV is a rare
vestibular disorder of various aetiologies (eg,
ototoxic drugs, meningitis or Menie`re’s disease).4–6
Despite intensive examinations, the aetiology
remains unclear in approximately 50%.6
Little is known about the course of the disease,
especially the recovery. A few small case series have
reported contradictory recovery rates.5 7–9 In a
report on 11 patients with idiopathic BV (eight
patients with simultaneous and three patients
with sequential onset of BV), partial recovery
was detected in four patients with simultaneous
and in all three patients with sequential BV after a
follow-up of 1–7 years. Complete recovery did not
occur in any of the patients.5 Improvement of
vestibular function was also described in single
cases of different aetiologies,9 in particular when
BV was caused by serous rather than suppurative
destructive labyrinthitis.4 10 11 In contrast, in a
5 year follow-up study7 of seven patients with
BV, Baloh et al did not find significant improve-
ment in vestibular excitability. Furthermore, in a
recent study, the effectiveness of immunosuppres-
sive treatment of patients with BV and inner ear
antibodies was moderate in four of 12 patients and
only transient in two of them.8 Based on our
clinical experience, the prognosis of BV is less
favourable than hitherto reported. Therefore, we
examined 82 patients with BV of various aetiolo-
gies and clinically re-evaluated them after a mean
follow-up time of 51 (36) months (range 3 months
to 13 years). The initial diagnosis of BV and clinical
re-evaluation were made according to a standar-
dised protocol, including a neuro-ophthalmological
and neuro-otological workup. We not only deter-
mined the frequency and extent of recovery or
worsening of vestibular function and their depen-
dence on the aetiology of BV, but also the
impairment of quality of life.
PATIENTS AND METHODS
The diagnosis of BV was based on the following
criteria: (1) a pathological head thrust test,2 3 which
indicates a high frequency deficit of the VOR and/
or (2) bilaterally diminished or absent caloric
responses on an electronystagmogram (ENG),
indicating a low frequency deficit.4 12
Complete BV was characterised by pathological
head thrust tests and the absence of caloric
responses on both sides.
Incomplete BV was characterized by one of the
following responses:
c bilateral pathological head thrust tests and a
calorically elicited nystagmus with a mean
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peak slow phase velocity (SPV) of ,5u/s for each caloric
irrigation on both sides;
c bilateral pathological head thrust tests and caloric responses
.5u/s on one or both sides; or
c normal head thrust tests and loss of bilateral responses or
reduced responses (,5u/s) to caloric irrigation on both sides.
Definition of aetiology
Patients were classified as having either a ‘‘definite’’ or
‘‘probable’’ cause of BV. This classification was based on the
previously published literature on BV.4 5 The aetiologies were
carefully reassessed by the senior authors.
A total of 163 patients who had been diagnosed with BV in
the Department of Neurology, University of Munich, between
1993 and 2005 were contacted. Ninety-five patients responded
and 82 finally came to the follow-up examinations. The current
address could not be determined for 37 patients, 28 patients did
not respond and three had died in the meantime.
A standardised detailed history was obtained from all patients
at the first and follow-up examinations. The following
parameters were assessed: (1) recurrent (preceding or current)
attacks of vertigo or dizziness: onset, duration, time course,
frequency and associated symptoms (oscillopsia, double vision,
blurred vision, loss of sight, phonophobia, photophobia, head-
ache, nausea, vomiting); (2) unsteadiness of gait, in particular in
the dark or on uneven ground; (3) oscillopsia during head
movements or during locomotion; (4) recurrent or sustained ear
symptoms (tinnitus, hearing loss, fullness of the ear); (5) past
medical history with regard to migraine, polyneuropathy,
exposure to toxins, antibiotics or diuretics, cardiovascular risk
factors (eg, arterial hypertension, diabetes mellitus) or other
neurological, ophthalmological, ENT or internal diseases (eg,
autoimmune disorders, cancer); (6) family history of impaired
audiovestibular function.
All patients underwent a complete neurological, neuro-
ophthalmological and neuro-otological examination. The
neuro-ophthalmological and neuro-otological examination
included the head thrust test, evaluation for spontaneous
nystagmus with Frenzel’s goggles, gaze evoked nystagmus,
smooth pursuit, saccades, optokinetic nystagmus, visual fixa-
tion suppression of the VOR, rebound nystagmus and head
shaking nystagmus (for general neuro-ophthalmological and
neuro-otological testing, see Brandt and Strupp13). A cerebellar
ocular motor disorder was characterised by either one or a
combination of the following ocular motor dysfunctions:
rebound nystagmus, downbeat nystagmus, pathological sac-
cades and pathological visual fixation suppression of the VOR.
ENG with bithermal caloric testing (30uC and 44uC) was
performed in all patients to determine mean peak SPV using
Igor Pro Wave Metric software (V.3.13). We determined the
mean peak SPV of the 10 fastest slow phases for each side and
temperature. For technical reasons, three ENGs performed at
follow-up could not be evaluated; these patients were therefore
excluded. None of the patients was on medications with a
relevant influence on vestibular testing, such as benzodiaze-
pines, analgesics or anticonvulsants.
A cranial MRI was performed in 78 patients. Specific
laboratory tests were initiated according to the suspected
specific aetiologies (autoantibodies against inner ear structures,
vitamin B12 and folate, antinuclear antibodies, complement
factors C3 and C4 and CSF test). Autoantibodies against inner
ear structures were determined as previously reported by our
group.14 All patients performed vestibular exercises and balance
training using a video or DVD for at least 3 months.15
Subjective parameters
The patients were asked: (1) to evaluate the impairment of their
health related quality of life measured at the time of the second
evaluation with a self-classification system (with respect to
mobility, self-care and daily activities) consisting of four degrees
of severity in comparison with their situation before manifesta-
tion of BV (not impaired and slightly, moderately or severely
impaired); (2) to evaluate the course of their disease by
comparing the change in balance and gait unsteadiness
(unchanged, worse, improved); (3) if they had noticed changes
or difficulties in spatial navigation.
Statistical analysis
The mean peak SPV of each patient was calculated as follows:
peak SPV (u/s) after caloric testing at 30uC and 44uC for the
right and left sides were added up, and the sum was divided by
4. For statistical analysis, a main effects ANOVA (Statistica 6.0,
Table 1 Number of patients (%) in subgroups with different aetiologies and types of manifestation of
bilateral vestibulopathy* and number of patients with bilateral pathological head thrust tests and
electronystagmogram at the initial and follow-up examinations
Patients
(n (%))
ENG (mean (SD) peak SPV)
Bilateral pathological head
thrust tests
Initial Follow-up Initial (n) Follow-up (n)
Aetiology of BV 79 (100) 3.0 (3.5) 2.1 (2.8) 72 72
Antibiotics 10 (13) 2.3 (2.2) 0.8 (1.1) 8 9
Meningitis 7 (9) 1.0 (1.4) 1.9 (1.6) 7 6
Pathological inner ear antibodies 7 (9) 1.8 (2.0) 1.6 (2.0) 7 7
Menie`re’s disease 6 (8) 2.5 (3.0) 1.9 (3.2) 6 5
Miscellaneous{ 10 (13) 6.6 (4.8){ 4.4 (5.6) 9 9
Idiopathic{ 39 (49) 4.9 (6.1){ 3.9 (5.4) 35 36
Sequential BV 30 (38) 3.0 (3.5) 2.1 (2.8) 28 30
Slowly progressive BV 49 (62) 4.6 (5.8) 3.6 (5.4) 47 45
*Some of the percentages have been rounded up, others rounded down.
{The mean peak SPV of each patient was calculated as follows: all peak SPVs after caloric testing at 30uC and 44uC for the right
and left sides were added, and the sum was divided by 4.
{Only those patients were included who showed either a mean peak SPV (5u/s and/or had a bilateral pathological head thrust
test.
The total number of all patients was 79.
BV, bilateral vestibulopathy; ENG, electronystagmogram; SPV, slow phase velocity.
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Statsoft) was performed with mean peak slow phase velocities
of caloric responses at the two time points as dependent
variables and the following categorical predictors: ‘‘aetiology’’
(see table 1, six levels), ‘‘course’’ (progressive vs sequential, two
levels), ‘‘gender’’ (two levels), ‘‘age’’ (patients grouped by
decades, eight levels) and ‘‘completeness’’ (complete vs incom-
plete BV, two levels). Significance was defined as an alpha level
of 0.05. Data in the figure are given as mean (95% confidence
intervals).
RESULTS
Study population
Eighty-two patients with a mean age of 56.3 (SD 17.6) years at
the time of diagnosis were included. The diagnosis was made,
on average, 71 (119) months (median 36) after the onset of the
first symptoms. The majority were male (72%, n = 59, mean age
55.8 (15.2) years; females 28%, n = 23, mean age 62.9
(15.0) years). Thirty-two per cent of all patients fulfilled the
above listed criteria for complete BV (n = 26) and the remaining
(n = 56) for incomplete BV. In the latter, a subgroup (n = 5)
with bilaterally normal head thrust tests, but pathological
caloric responses, was identified.
The ENG of three patients could not be evaluated for
technical reasons and thus the following statistical analyses
refer to the remaining 79 patients.
Time course of the disease manifestation
Episodes of vertigo or dizziness preceded the manifestation of
BV in 38% of patients (n = 30) who had a so-called sequential
course. BV developed simultaneously, most often slowly
progressively in 62% of all patients (n = 49), as indicated by a
patient history of progressive unsteadiness of gait and oscillop-
sia.
Aetiology of BV
The definite or probable cause was defined in 51% of all patients
(n = 40). The most frequent causes were adverse effects of
aminoglycosides (13% of total, n = 10): gentamycin only in six
(of 10) patients, gentamycin plus other antibiotics (streptomy-
cin, vancomycin, penicillin) in three (of 10) patients and
gentamycin plus furosemide in one (of 10) patients. Nine per
cent of patients (n = 7) had suffered from meningoencephalitis
and another 9% (n = 7) had autoantibodies against inner ear
structures. Another group (8% of the total, n = 6) consisted of
patients with Menie`re’s disease. There was also a group (13% of
the total, n = 10) with ‘‘miscellaneous’’ causes: side effects
caused by high dose therapy with furosemide (n = 1), oto-
sclerosis (n = 1), vitamin B12 deficiency (n = 2), alcoholism
(n = 2), positive family history for inner ear disease (n = 1), an
association of BV with spinocerebellar ataxia type 6 (n = 1) or
systemic autoimmune diseases (Sjo¨gren’s syndrome and ulcera-
tive colitis) (n = 2). The underlying aetiology of BV remained
unclear in 49% (so-called idiopathic BV; n = 39).
BV and its association with cerebellar symptoms
Ten of all included patients with BV (nine males, one female)
were also diagnosed as having a cerebellar syndrome at the first
examination. The following cerebellar signs were found:
cerebellar ocular motor disorders in all 10 patients, ataxia of
the limbs in nine patients and dysarthrophonia in four patients.
None of the other included patients with BV developed a
cerebellar syndrome in the period between the first and the
second examinations. BV was caused by spinocerebellar ataxia
Figure 1 (A, B) Response to caloric irrigation in the initial and follow-up
electronystagmogram (mean (SD) peak slow phase velocity (SPV)) in
patients with sequential and slowly progressive bilateral vestibulopathy
(BV) (A) and for subgroups with BV of various aetiologies (B). Filled
column, first examination; open column, follow-up examination. Misc,
miscellaneous; antibodies, pathological inner ear antibodies. Symbols in
the columns (square, diamond) = median; horizontal lines of the
boxes = 25th and 75th percentiles; whiskers above and below the
boxes = minimum and maximum values.
Table 2 Subjective evaluation of the course of the
disease, health related quality of life and spatial navigation
at the time of follow-up
Subjective evaluation
Patients
(n (%))
Quality of life
Not impaired 13 (16)
Slightly impaired 33 (42)
Moderately impaired 19 (24)
Severely impaired 14 (18)
Spatial orientation
Not impaired 69 (87)
Impaired 10 (13)
Disease course
Unchanged 34 (43)
Worse 22 (28)
Improved 23 (29)
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(n = 1) and alcoholism (n = 2). The other patients had
idiopathic BV.
Cranial imaging
MRI studies were performed in 78 of all included 82 patients.
The following abnormalities were found: cerebellar atrophy
(n = 6), other cerebellar lesions (eg, cerebellar infarction, n = 2),
unilateral acoustic neuroma (n = 1), generalised cerebral atro-
phy (n = 4) and supra- or infratentorial vascular lesions (n = 10).
Follow-up with re-evaluation of vestibular function
The time between the initial diagnosis and follow-up examina-
tion was 51 (36) months (range 3 months to 13 years; median
41 months). The initial ENG showed no significant differences
in response to caloric irrigation with respect to the aetiology
subgroups or time course of manifestation. Table 1 shows the
mean peak SPV after caloric irrigation and the number of
patients with bilateral pathological head thrust tests at the first
and follow-up examinations. The results are also given for
different aetiologies and time courses of manifestation. In
general, the mean peak SPV after caloric irrigation tended to
decrease at follow-up, but not significantly.
This was true for the total study population as well as for
patients with different time courses of manifestation of BV
(fig 1A) and aetiologies (fig 1B). Only patients with BV due to
meningitis had slightly increased mean peak SPVs at the follow-
up investigation (n = 7). Single analysis of all patients showed
that a substantial improvement in caloric responses >5u/s
occurred in two patients on both sides (idiopathic n = 1,
Sjo¨gren’s syndrome n = 1) and in eight patients on one side
(idiopathic n = 6, meningitis n = 1, Menie`re’s disease n = 1).
The patient with Sjo¨gren’s syndrome had received immuno-
suppressive treatment with cortisone and azathioprine. The
statistical analysis of vestibular outcome with regard to age,
gender and complete versus incomplete BV also revealed no
significant differences. Oscillopsia during head and body move-
ments were reported by 56% of all patients (n = 44) at the first
examination and by 53% (n = 42) at follow-up. Gait unsteadi-
ness was reported by all patients at both examinations.
Subjective evaluation of the course of the disease, quality of life
and spatial navigation
Table 2 gives an overview of how patients subjectively
evaluated the course of their disease, their health related quality
of life and their spatial navigation. Most of the patients (43%)
considered the course of their disease stable. The rest estimated
their clinical condition as either worsened (29%) or improved
(28%).
As regards the different aetiology subgroups (table 3), only
four of six patients with Menie`re’s disease felt that they had
improved at follow-up. These patients had been treated with
high doses of betahistine dihydrochloride (48 mg three times
daily). At follow-up, attacks of vertigo had completely stopped
in three of these patients, and the duration and frequency of
attacks were markedly decreased in one patient. The majority of
patients (42%) stated that BV caused a slight impairment of
their health related quality of life (24% moderate and 18%
severe impairment). Only a minority of patients (16%) felt that
BV had not impaired their quality of life. Thirteen per cent of
patients had noticed an impaired spatial navigation.
DISCUSSION
The major finding of this follow-up study in patients with BV
was that, in general, vestibular function remained unchanged
with a non-significant tendency of slow worsening. The
vestibular outcome was independent of the underlying causa-
tive factors, type of manifestation, severity of vestibular loss,
age and gender. This supports the findings of a longitudinal
study7 in a small group of seven patients with BV of different
aetiologies and 57 healthy subjects who returned for yearly
examinations of vestibular function over a period of 5 years. In
this study, no improvement was found in BV patients; the
normal older subjects (all over the age of 75 years) exhibited an
age related decrement in their vestibular responses without any
associated symptoms or signs of disequilibrium. It is known
from various studies that all structures relevant for vestibular
function (ie, the vestibular end organs and central vestibular
pathways) degenerate continuously with age. Hair cell loss
precedes those seen in the vestibular nerve and Scarpa’s
ganglion.16–19 Thus it can be assumed that the mild decrement
in vestibular responses in our study can be attributed to
progression of the disease as well as vestibular aging. Because of
the study design of our and previous investigations,5 7–9 most of
the patients presented with a chronic condition. This implies
that those patients with acute onset of BV and early recovery
(such as patients in the intensive care unit with BV caused by
meningitis or treatment with ototoxic antibiotics) might
remain undetected by this approach. The latter argument is
supported by the improvement of patients with BV due to
meningitis in our study. This is supported by previous case
reports. It has been stated that patients with serous rather than
suppurative meningitis can exhibit partial recovery.10 11
In our study, none of the patients with BV caused by ototoxic
antibiotics showed a substantial improvement. However,
regeneration of receptor cells and subsequent functional
recovery after (gentamycin induced) damage of the auditory
and vestibular systems in many vertebrates is well known.20 21
The subjective evaluation of the course of the disease was
similar to the results of our objectively achieved findings for
vestibular testing. Most of the patients estimated their clinical
condition as being either unchanged or worse. In particular,
only a minority of patients reported an improvement in gait
unsteadiness. Part of this improvement might be due to
vestibular exercises and balance training, which all of our
patients had for at least 3 months. The usefulness of vestibular
rehabilitation in unilateral vestibular failure15 and BV22 23 has
been reported previously. The improvement after vestibular
rehabilitation with clear locomotor gains has been described in
approximately 50% of BV patients who received intensive
training over 3–12 months.22 Only patients with Menie`re’s
disease frequently assessed their course of disease as being
favourable. This might be explained by spontaneous or drug
induced reduction or cessation of vertigo attacks in the later
stage of the disease.
Table 3 Subjective evaluation of the course of the disease
Aetiology
Worse
(n (%))
Unchanged
(n (%))
Improved
(n (%))
Idiopathic 14 (36) 17 (44) 8 (21)
Antibiotics 3 (30) 4 (40) 3 (30)
Pathological inner ear antibodies 1 (14) 4 (57) 2 (29)
Meningitis 3 (43) 3 (43) 1 (14)
Menie`re’s disease 1 (17) 1 (17) 4 (67)
Miscellaneous 1 (10) 5 (50) 4 (40)
The results are given for different subgroups (some of the percentages have been
rounded up, others rounded down).
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About two-thirds of our patients rated their health related
quality of life as slightly to moderately impaired. Nearly 90% of
patients estimated their spatial navigation as unchanged since
the first manifestation of BV. A previous study had shown that
complete BV can lead to impaired spatial memory and
navigation associated with hippocampal atrophy.1
This study has some limitations as to completeness of
vestibular testing with respect to otolith (vestibular evoked
myogenic potentials) and canal function, dynamic visual acuity,
evaluation of hearing impairment, posturography and gait
analysis, or the application of a health self-classification system
such as the EQ-5D24 or specific dizziness rating scales. None of
these tests was included because they were not routinely
performed at the first examination. We chose the head thrust
test and bithermal caloric testing with 30uC and 44uC (instead
of rotational testing) because it is the gold standard for
documenting BV13 and allows side specific assessment of
(residual) vestibular function. One may argue that in patients
who already have minimal to no caloric responses to start with,
it is not surprising that no statistical difference was seen at
follow-up. Caloric testing with ice water would have been an
additional tool to detect slight improvement. However, the
main goal of this study was to investigate a relevant
improvement or worsening of vestibular function over time.
In addition, according to our experience with many patients,
caloric testing with ice water is not well tolerated and was
therefore not routinely used in our patients.
In conclusion, our data support the view that more than 80%
of patients with BV do not improve. Thus the prognosis of BV is
less favourable than assumed. This emphasises the need for
intensive vestibular rehabilitation25 to reduce the burden of
disease.
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